January 2, 2024: 2024 will be a landmark year for Cosmos Pharmaceuticals LLC with its revolutionary medication adherence platform introduction to the early adopters! The year kicks off with Cosmos' much-anticipated device, FortisKap, landing in the hands of patients in our study groups. This platform promises to revolutionize medication adherence offering real time dosing timeframes, dosing quantities and predictive risk management. Cosmos will showcase its innovation at the upcoming RESI JPM conference in San Francisco next week and connect with key investors and potential partners. "Most Investable StartUp" recognition: Life Science Nation’s recognition validates Cosmos' potential and supports the company's $1.25M seed capital raise. This funding supports commercialization development and entry into the market. #RESIJPM #RESIJPM24 #RESISANFRAN
Congrats! Well deserved!
Congrats! Well deserved!
Congratulations Alex! Super good news entering into the New Year!
Congratulations!
Founding Member at Hexis Energy Trading, LLC
9moAn amazing accomplishment for the entire Cosmos group and certainly well deserved.